| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/2010 | EP2165698A1 Cosmetic composition designed to protect damaged skin |
| 03/24/2010 | EP2165694A1 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
| 03/24/2010 | EP2165604A1 Stable microbiocidal composition |
| 03/24/2010 | EP2164967A2 Reduction of off-target rna interference toxicity |
| 03/24/2010 | EP2164966A2 Dsrna for treating viral infection |
| 03/24/2010 | EP2164965A2 A primary micro rna expression cassette |
| 03/24/2010 | EP2164866A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| 03/24/2010 | EP2164865A2 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds |
| 03/24/2010 | EP2164856A1 Processes related to making capecitabine |
| 03/24/2010 | EP2164850A2 N-substituted azaindoles and methods of use |
| 03/24/2010 | EP2164849A2 Pyridopyrazine derivatives, process of manufacturing and uses thereof |
| 03/24/2010 | EP2164848A1 Polymorphic form of granisetron base, methods for obtaining it and formulation containing it |
| 03/24/2010 | EP2164847A1 3-aza-bicyclo[3.3.0]octane compounds |
| 03/24/2010 | EP2164846A2 Heteroaryl substituted thiazoles and their use as antiviral agents. |
| 03/24/2010 | EP2164845A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology |
| 03/24/2010 | EP2164843A1 Pyridazinone derivates |
| 03/24/2010 | EP2164842A2 Thiazoles and pyrazoles useful as kinase inhibitors |
| 03/24/2010 | EP2164840A2 Modulators of cftr |
| 03/24/2010 | EP2164838A1 Novel compound |
| 03/24/2010 | EP2164837A1 Novel compounds |
| 03/24/2010 | EP2164834A2 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
| 03/24/2010 | EP2164833A2 Quinazolinamide derivatives |
| 03/24/2010 | EP2164829A1 A new peptide deformylase inhibitor compound and manufacturing process thereof |
| 03/24/2010 | EP2164827A2 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 03/24/2010 | EP2164825A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them |
| 03/24/2010 | EP2164572A2 Carbamoyl-cyclohexanes for treating acute mania |
| 03/24/2010 | EP2164518A1 Formulations for the oral administration of therapeutic agents and related methods |
| 03/24/2010 | EP2164517A1 Il- 18 and protein kinase r inhibition for the treatment of copd |
| 03/24/2010 | EP2164505A1 Treatment of chronic lung disease |
| 03/24/2010 | EP2164501A1 Sulphated xylans for treatment or prophylaxis of respiratory diseases |
| 03/24/2010 | EP2164500A1 The use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants |
| 03/24/2010 | EP2164499A1 Treatment of tardive dyskinesia with pyridoxal 5'-phosphate |
| 03/24/2010 | EP2164498A1 Pregnancy hormone combination for treatment of autoimmune diseases |
| 03/24/2010 | EP2164497A1 A drug delivery system for the prevention of cerebral vasospasm |
| 03/24/2010 | EP2164495A1 Use of derivatives of 3-oxo-2,3-dihydro-5h-thiazolofý3,2-a¨pyrimidine or of 3-oxo-2,3-dihydro-5h-selenazoloý3,2-a¨pyrimidine or of 3-oxo-1,2,3-trihydro-5h-imidazoloý1,2-a¨pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer |
| 03/24/2010 | EP2164494A1 Methods of treatment |
| 03/24/2010 | EP2164492A1 (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia |
| 03/24/2010 | EP2164490A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. |
| 03/24/2010 | EP2164486A2 Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders |
| 03/24/2010 | EP2164484A1 Use of nitric oxide-releasing statins in the treatment of pulmonary arterial hypertension |
| 03/24/2010 | EP2164483A2 Transglutaminase inhibitor comprising chlorogenic acid and a method for producing thereof |
| 03/24/2010 | EP2164480A1 Mutual prodrugs and methods to treat cancer |
| 03/24/2010 | EP2164479A2 New sigma-receptor ligands with anti-apoptotic and/or pro-apoptotic properties over cellular biochemical mechanisms, with neuroprotective, anti- cancer, anti-metastatic and anti-(chronic) inflammatory action |
| 03/24/2010 | EP2164477A1 Pharmaceutical composition having a trihydroxy-chromenone derivative |
| 03/24/2010 | EP2164476A1 Topical composition for treating pain |
| 03/24/2010 | EP2164472A1 Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol |
| 03/24/2010 | EP2164469A2 Stable formulation of amorphous perindopril salts, a process for the preparation thereof on industrial scale and use thereof in the treatment of hypertension |
| 03/24/2010 | EP2164465A1 Self-emulsifying formulation of tipranavir for oral administration |
| 03/24/2010 | EP2164463A1 Concentrate esmolol |
| 03/24/2010 | EP2164457A2 Method of regulating hair growth |
| 03/24/2010 | EP2164331A1 Boron-containing small molecules |
| 03/24/2010 | EP2164329A2 Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification |
| 03/24/2010 | EP2164326A1 Amide compounds and the use thereof |
| 03/24/2010 | EP2164325A1 Oxyimino compounds and the use thereof |
| 03/24/2010 | EP2089378B1 Short-acting benzodiazepine salts and their polymorphic forms |
| 03/24/2010 | EP2081566B1 Improved biological effects of compositions comprising rosmarinic acid |
| 03/24/2010 | EP2046791B1 Urea derivatives of tropane, their preparation and their therapeutic application |
| 03/24/2010 | EP1877390B1 Benzisoxazole piperazine compounds and methods of use thereof |
| 03/24/2010 | EP1877059B1 Micronized tanaproget and compostions containing same |
| 03/24/2010 | EP1839662B1 Antitumor agent |
| 03/24/2010 | EP1813294B1 Adhesion preventive and method of preventing adhesion |
| 03/24/2010 | EP1809270B1 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 03/24/2010 | EP1789404B1 Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| 03/24/2010 | EP1745047B1 Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine adenosine-a2a- receptor antagonists |
| 03/24/2010 | EP1711164B1 Method of treating acute rhinosinusitis |
| 03/24/2010 | EP1710236B1 Derivatives of pyridine and quinoline |
| 03/24/2010 | EP1644357B9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/24/2010 | EP1620060B1 Methods and devices for the sustained release of multiple drugs |
| 03/24/2010 | EP1615699B1 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/24/2010 | EP1560821B1 Antibacterial agents |
| 03/24/2010 | EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/24/2010 | EP1328511B1 Substituted (e)-styryl benzylsulfones for treating proliferative disorders |
| 03/24/2010 | EP1315506B1 Phospholipid derivatives of valproic acid and mixtures thereof |
| 03/24/2010 | EP1112005B2 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid |
| 03/24/2010 | EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 03/24/2010 | EP1009399B1 Gaba analogs to prevent and treat gastrointestinal damage |
| 03/24/2010 | EP1003370B1 Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 03/24/2010 | CN201426858Y Clopidogrel hydrogen shlfate and aspirin double-layer tablet |
| 03/24/2010 | CN201426857Y Amoxicillin long-acting granular pill |
| 03/24/2010 | CN201426856Y Tilmicosin enteric coated granule |
| 03/24/2010 | CN201426855Y Florfenicol enteric coated granule |
| 03/24/2010 | CN101680008A Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors |
| 03/24/2010 | CN101679979A Administering antisense oligonucleotides complementary to human apolipoprotein b |
| 03/24/2010 | CN101679962A Single-stranded cyclic rna, and method for production thereof |
| 03/24/2010 | CN101679478A 17ss-cyano-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 03/24/2010 | CN101679477A 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 03/24/2010 | CN101679476A 23-substituted bile acids as TGR5 modulators and methods of use thereof |
| 03/24/2010 | CN101679472A Compounds for preventing or treating viral infections and methods of use thereof |
| 03/24/2010 | CN101679471A aminoglycoside antibiotics targeting bacterial 16s ribosomal rna |
| 03/24/2010 | CN101679470A Method for production of sugar oxazoline derivative |
| 03/24/2010 | CN101679469A Use of modified oligo-beta-(1,3)-glucanes for treating diseases of the immune system, oligo-beta- (1,3v-glucane-(1,3)- mannose, oligo-beta-(1,3)-glucane-(1,3)- mannitol and derivatives thereof, method |
| 03/24/2010 | CN101679457A Piperazine and [1,4] diazepan derivatives as NK antagonists |
| 03/24/2010 | CN101679456A Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| 03/24/2010 | CN101679455A New progesterone receptor modulators |
| 03/24/2010 | CN101679454A Antimicrobial heterocyclic compounds for treatment of bacterial infections |
| 03/24/2010 | CN101679451A compositions comprising c-13 alkoxyether macrolide compounds and phenylpyrazole compounds |
| 03/24/2010 | CN101679448A spiroindolinone derivatives |
| 03/24/2010 | CN101679447A pyrimidodiazepinone derivative |
| 03/24/2010 | CN101679446A 3,3-spiroindolinone derivatives |
| 03/24/2010 | CN101679445A Pyrimidinedione derivatives and methods of use thereof |